Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2084405 | European Journal of Pharmaceutics and Biopharmaceutics | 2008 | 7 Pages |
Abstract
No differences were observed between the binding/release capacity and lipoprotein interactions of any of the propofol preparations tested. We propose that clinical observations of inconsistent propofol activity are related to variations in the lipoprotein profile, enzyme activity or genetic disorders of individual patients, rather than to the propofol preparation itself.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Maximilian Schicher, Margit Polsinger, Albin Hermetter, Ruth Prassl, Andreas Zimmer,